Tianchuan Zhu

Zhuhai, 519000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Engineering BiTE-inspired IPSC-exosomes to potentiate CAR-T cell therapy against lung cancer.

Engineering BiTE-inspired IPSC-exosomes to potentiate CAR-T cell therapy against lung cancer.

Journal: Journal of nanobiotechnology

Published: October 21, 2025

Engineered nanovesicles as a DC vaccine to enhance the antitumor efficacy of CAR-T cells against solid tumors.

Engineered nanovesicles as a DC vaccine to enhance the antitumor efficacy of CAR-T cells against solid tumors.

Journal: Journal of nanobiotechnology

Published: September 28, 2025

Inhalable nanovesicles loaded with a STING agonist enhance CAR-T cell activity against solid tumors in the lung.

Inhalable nanovesicles loaded with a STING agonist enhance CAR-T cell activity against solid tumors in the lung.

Journal: Nature communications

Published: March 27, 2024

Lung metastasis and recurrence is mitigated by CAR macrophages, in-situ-generated from mRNA delivered by small extracellular vesicles.

Lung metastasis and recurrence is mitigated by CAR macrophages, in-situ-generated from mRNA delivered by small extracellular vesicles.

Journal: Nature communications

Published: January 29, 2024

Multifunctional Bispecific Nanovesicles Targeting SLAMF7 Trigger Potent Antitumor Immunity.

Multifunctional Bispecific Nanovesicles Targeting SLAMF7 Trigger Potent Antitumor Immunity.

Journal: Cancer immunology research

Published: December 27, 2023

Sequential Targeting Hybrid Nanovesicles Composed of Chimeric Antigen Receptor T-Cell-Derived Exosomes and Liposomes for Enhanced Cancer Immunochemotherapy.

Sequential Targeting Hybrid Nanovesicles Composed of Chimeric Antigen Receptor T-Cell-Derived Exosomes and Liposomes for Enhanced Cancer Immunochemotherapy.

Journal: ACS nano

Published: August 25, 2023

Delivery of SAV-siRNA via Exosomes from Adipose-Derived Stem Cells for the Treatment of Myocardial Infarction.

Delivery of SAV-siRNA via Exosomes from Adipose-Derived Stem Cells for the Treatment of Myocardial Infarction.

Journal: Tissue engineering and regenerative medicine

Published: May 12, 2023

Target delivery of a PD-1-TREM2 scFv by CAR-T cells enhances anti-tumor efficacy in colorectal cancer.

Target delivery of a PD-1-TREM2 scFv by CAR-T cells enhances anti-tumor efficacy in colorectal cancer.

Journal: Molecular cancer

Published: February 07, 2023

Inhalable CAR-T cell-derived exosomes as paclitaxel carriers for treating lung cancer.

Inhalable CAR-T cell-derived exosomes as paclitaxel carriers for treating lung cancer.

Journal: Journal of translational medicine

Published: January 19, 2023

Genetically Programmable Vesicles for Enhancing CAR-T Therapy against Solid Tumors.

Genetically Programmable Vesicles for Enhancing CAR-T Therapy against Solid Tumors.

Journal: Advanced materials (Deerfield Beach, Fla.)

Published: November 29, 2022

An iPSC-derived exosome-pulsed dendritic cell vaccine boosts antitumor immunity in melanoma.

An iPSC-derived exosome-pulsed dendritic cell vaccine boosts antitumor immunity in melanoma.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: September 20, 2022

Functionalized biomimetic nanoparticles combining programmed death-1/programmed death-ligand 1 blockade with photothermal ablation for enhanced colorectal cancer immunotherapy.

Functionalized biomimetic nanoparticles combining programmed death-1/programmed death-ligand 1 blockade with photothermal ablation for enhanced colorectal cancer immunotherapy.

Journal: Acta biomaterialia

Published: August 10, 2022

Showing 1-12 of 14

Last Updated: 09/26/2026